Items where Author is "McArdle, SE"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 18.

Journal article

Abdel-Fatah, TMA, McArdle, SE ORCID: 0000-0001-6929-9782, Agarwal, D, Moseley, PM, Green, AR, Ball, GR ORCID: 0000-0001-5828-7129, Pockley, AG ORCID: 0000-0001-9593-6431, Ellis, IO, Rees, RC and Chan, SYT, 2015. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research. ISSN 1078-0432

Ali, SA, Rezvan, H, McArdle, SE ORCID: 0000-0001-6929-9782, Khodadadi, A, Asteal, FA and Rees, RC, 2009. CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model. Parasite Immunology, 31 (7), pp. 373-383.

McArdle, SE ORCID: 0000-0001-6929-9782 and Rees, RC, 2009. Tumor immunlogy: new perspectives [review]. Cancer Research, 15 (18), pp. 7157-7159.

Riley, CL, Mathieu, MG, Clark, RE, McArdle, SE ORCID: 0000-0001-6929-9782 and Rees, RC, 2009. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? Cancer Immunology Immunotherapy, 58 (9), pp. 1489-1499.

McArdle, SE ORCID: 0000-0001-6929-9782, 2008. Cancer vaccines: uses of HLA transgenic mice compared to genetically modified mice. Frontiers in Bioscience, 14 (12), pp. 4640-4651.

Walton, TJ, Li, G, Seth, R, McArdle, SE ORCID: 0000-0001-6929-9782, Bishop, MC and Rees, RC, 2008. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. DNA demethylation and histone deacetylation inhibition act synergistically to re-express oestrogen receptor beta and induce apoptosis in prostate cancer cell-lines [working title], 68 (2), pp. 210-222.

Miles, AK ORCID: 0000-0002-5388-938X, Rogers, A, Parkinson, R, Rees, RC and McArdle, SE ORCID: 0000-0001-6929-9782, 2008. Overview of prostate biomarkers as potential targets for immunotherapy [review]. Current Cancer Therapy Reviews, 4 (2), pp. 86-95.

Assudani, DP, Li, G, Line, A, Fuming, C, Miles, AK ORCID: 0000-0002-5388-938X, Rees, RC and McArdle, SE ORCID: 0000-0001-6929-9782, 2008. SEREX analysis of prostate cancer cDNA libraries: identification of metastasis associated antigen (MTA1) [in press]. Open Biochemistry Journal.

Rogers, A, Miles, A, McArdle, SE, Mcculloch, T, Powe, D, Bishop, M and Rees, R, 2006. Identification and characterisation of T21: A novel cancer testis antigen over expressed in prostate cancer. European Urology Supplements, 5 (14), p. 799. ISSN 1569-9056

Li, G, Ali, SA, McArdle, SE ORCID: 0000-0001-6929-9782, Mian, S, Ahmad, M ORCID: 0000-0002-6074-2001, Miles, A ORCID: 0000-0002-5388-938X and Rees, RC, 2005. Immunity to tumour antigens. Current Pharmaceutical Design, 11 (27), pp. 3501-3509. ISSN 1381-6128

Ahmad, M ORCID: 0000-0002-6074-2001, Rees, RC, McArdle, SE ORCID: 0000-0001-6929-9782, Li, G, Mian, S, Entwisle, C, Loudon, P and Ali, SA, 2005. Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4(+) T cells in mice failing immunotherapy with DISC-mGM-CSF. International Journal of Cancer, 115 (6), pp. 951-959. ISSN 0020-7136

McArdle, SE ORCID: 0000-0001-6929-9782, Ali, SA, Li, G, Mian, S and Rees, RC, 2003. Phenotypic and functional differences of dendritic cells generated under different in vitro conditions. Methods in Molecular Medicine, 81, pp. 359-375.

Mian, S, Ball, G ORCID: 0000-0001-5828-7129, Hornbuckle, J, Holding, F, Carmichael, J, Ellis, I, Ali, S, Li, G, McArdle, SE ORCID: 0000-0001-6929-9782, Creaser, C and Rees, R, 2003. A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in v. Proteomics, 3 (9), pp. 1725-1737.

Rees, RC, McArdle, SE ORCID: 0000-0001-6929-9782, Mian, S, Li, G, Ahmad, M ORCID: 0000-0002-6074-2001, Parkinson, R and Ali, SA, 2002. Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer. Current Opinion in Molecular Therapeutics, 4 (1), pp. 49-53. ISSN 1464-8431

McArdle, SE ORCID: 0000-0001-6929-9782, Rees, RC, Mulcahy, KA, Saba, J, McIntyre, CA and Murray, AK, 2000. p53 conformational mutants are killed preferentially by cytotoxic T lymphocytes generated in vitro using dendritic cells pulsed with new wild-type p53 peptide. Cancer Immunology Immunotherapy, 49 (8).

Murray, AK, McArdle, SE, Saba, J, Mulcahy, KA, McIntyre, CA and Rees, RC, 1998. Generation of cytotoxic T lymphocytes in vitro using wild-type p53 peptide-pulsed dendritic cells. Journal of Leukocyte Biology, p. 97. ISSN 0741-5400

Chapter in book

Assudani, DP, McArdle, SE ORCID: 0000-0001-6929-9782, Ahmad, M ORCID: 0000-0002-6074-2001, Li, G, Rees, RC and Ali, SA, 2008. Vaccination strategies for malignant diseases. In: Treatment of cancer. Hodder Arnold, p. 167.

Mueller, L, McArdle, SE ORCID: 0000-0001-6929-9782, Derhovanessian, E, Flad, T, Knights, AJ, Rees, RC and Pawelec, G, 2005. Current strategies for the identification of immunogenic epitopes of tumor antigens. In: Disis, ML, ed., Immunotherapy of Cancer. Humana Press.

This list was generated on Mon Sep 25 19:00:35 2017 UTC.